Tilray Brands (TLRY) Return on Assets (2018 - 2026)

Tilray Brands' (TLRY) quarterly Return on Assets came in at 0.0% in Q2 2026, up 90.56% on a QoQ basis from 0.0% in Q1 2026.

Tilray Brands (TLRY) Return on Assets (2018 - 2026) Analysis & Trends

Tilray Brands (TLRY) has 9 years of Return on Assets data on file, last reported at 0.0% in Q2 2026.

Quarterly Return on Assets changed N/A year-over-year to 0.0% in Q2 2026, while the trailing twelve-month figure through May 2026 was 0.0% (changed N/A YoY) and the FY2026 annual result came in at 0.0%, up 1.0% from the prior year.
Return on Assets climbed to 0.0% in Q2 2026, from 0.0% in the prior quarter.
In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2022 to a low of 0.01% in Q3 2025.
A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
Annual changes were most pronounced in 2022 — Return on Assets changed 0 bps — and 2025, when it slipped 1 bps.
Tracing TLRY's Return on Assets over 5 years: stood at 0.0% in 2022, then sank by 202 bps to 0.0% in 2023, then surged by 80 bps to 0.0% in 2024, then sank by 1533 bps to 0.01% in 2025, then jumped by 95 bps to 0.0% in 2026.
The last three Return on Assets figures came in at 0.0% (Q2 2026), 0.0% (Q1 2026), and 0.01% (Q4 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROA (Qtr)
1	Haleon	43.83 Bn	42.86 Bn	-	0.00%
2	Teva Pharmaceutical Industries	42.87 Bn	39.22 Bn	2.15 Bn	0.00%
3	Zoetis	31.41 Bn	29.73 Bn	1.05 Bn	0.00%
4	Takeda Pharmaceutical	28.55 Bn	22.75 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.08 Bn	19.42 Bn	683.80 Mn	0.00%
6	Viatris	18.73 Bn	17.84 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.44 Bn	15.05 Bn	935.80 Mn	0.00%
8	Elanco Animal Health	11.75 Bn	11.22 Bn	798.00 Mn	0.00%
9	Dr Reddys Laboratories	10.11 Bn	9.94 Bn	-	0.00%
10	Tilray Brands	523.93 Mn	289.30 Mn	90.52 Mn	0.00%

Download Data